{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:13:51Z","timestamp":1777396431499,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,7,21]]},"DOI":"10.3233\/jad-200108","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T13:13:53Z","timestamp":1591708433000},"page":"691-701","source":"Crossref","is-referenced-by-count":6,"title":["Progression of Alzheimer\u2019s Disease by Self-Reported Cancer History in the Alzheimer\u2019s Disease Neuroimaging Initiative"],"prefix":"10.1177","volume":"76","author":[{"given":"Mackenzie E.","family":"Fowler","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Alabama, Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen L.","family":"Triebel","sequence":"additional","affiliation":[{"name":"Division of Neuropsychology, Department of Neurology, University of Alabama, Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Cutter","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama, Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[{"name":"University of Southern California Keck School of Medicine, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama, Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200108_ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2318-14-10","article-title":"A claims data-based comparison of comorbidity in individuals with and without dementia","volume":"14","author":"Bauer","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-200108_ref2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/01.WNL.0000152889.94785.51","article-title":"Alzheimer disease and cancer","volume":"64","author":"Roe","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e3181c91873","article-title":"Cancer linked to Alzheimer disease but not vascular dementia","volume":"74","author":"Roe","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/WNL.0b013e31829c5ec1","article-title":"Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study","volume":"81","author":"Musicco","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref5","doi-asserted-by":"crossref","first-page":"e1442","DOI":"10.1136\/bmj.e1442","article-title":"Inverse association between cancer and Alzheimer\u2019s disease: Results from the Framingham Heart Study","volume":"344","author":"Driver","year":"2012","journal-title":"BMJ"},{"key":"10.3233\/JAD-200108_ref7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-200108_ref14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fphys.2014.00423","article-title":"Association of cancer history with Alzheimer\u2019s disease onset and structural brain changes","volume":"5","author":"Nudelman","year":"2014","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-200108_ref15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-200108_ref16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jalz.2009.07.038","article-title":"Current Alzheimer\u2019s disease clinical trials: methods and placebo outcomes","volume":"5","author":"Schneider","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200108_ref17","unstructured":"Brown H , Prescott R (2015) Applied Mixed Models in Medicine. Statistics in Practice. 3rd ed. JohnWiley & Sons, Ltd, Hoboken, NJ."},{"key":"10.3233\/JAD-200108_ref18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-150847","article-title":"analyses of ApoE genotype-defined subgroups in clinical trials","volume":"50","author":"Kennedy","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200108_ref19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jalz.2013.03.003","article-title":"Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer\u2019s disease","volume":"10","author":"Kennedy","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200108_ref20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.0000000000001376","article-title":"Differences in Alzheimer disease clinical trial outcomes based on age of the participants","volume":"84","author":"Schneider","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-200108_ref21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trci.2015.03.001","article-title":"Using baseline cognitive severity for enriching Alzheimer\u2019s disease clinical trials: How does Mini-Mental State Examination predict rate of change?","volume":"1","author":"Kennedy","year":"2015","journal-title":"Alzheimers Dement (NY)"},{"key":"10.3233\/JAD-200108_ref22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-802973-2.00017-3","article-title":"Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors","volume":"138","author":"Jean-Pierre","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.3233\/JAD-200108_ref23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.mcna.2017.06.006","article-title":"Cognitive changes related to cancer therapy","volume":"101","author":"Vannorsdall","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.3233\/JAD-200108_ref24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence, mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"10.3233\/JAD-200108_ref25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","article-title":"A meta-analysis of the effects of chemotherapy on cognition in patients with cancer","volume":"39","author":"Hodgson","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.3233\/JAD-200108_ref26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/70.11.1093","article-title":"Dementia: Diagnosis and evaluation.","volume":"70","author":"Fleming","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.3233\/JAD-200108_ref27","doi-asserted-by":"crossref","first-page":"e181726","DOI":"10.1001\/jamanetworkopen.2018.1726","article-title":"Adolescent cognitive aptitudes and later-in-life Alzheimer disease and related disorders","volume":"1","author":"Huang","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-200108_ref28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.2017.35.8_suppl.234","article-title":"Sensitivity and specificity of self-reported cancer history compared to cancer registry","volume":"35","author":"Earle","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.3233\/JAD-200108_ref29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a009487","article-title":"Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries","volume":"147","author":"Bergmann","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-200108_ref30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canep.2017.07.010","article-title":"Validity of self-reported cancer history in the health examinees (HEXA) study: A comparison of self-report and cancer registry records","volume":"50","author":"Cho","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.3233\/JAD-200108_ref31","doi-asserted-by":"crossref","first-page":"e184080","DOI":"10.1001\/jamanetworkopen.2018.4080","article-title":"Association of concomitant use of cholinesterase inhibitors or memantine with cognitive decline in Alzheimer clinical trials: A meta-analysis","volume":"1","author":"Kennedy","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-200108_ref32","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/156720512804142976","article-title":"Biomarker positive and negative subjects in the ADNI cohort: Clinical characterization","volume":"9","author":"Kennedy","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-200108_ref33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MNM.0000000000001144","article-title":"Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation","volume":"41","author":"Pourhassan Shamchi","year":"2020","journal-title":"Nucl Med Commun"},{"key":"10.3233\/JAD-200108_ref34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.22368","article-title":"Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy","volume":"109,","author":"Inagaki","year":"2007","journal-title":"Cancer"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:21Z","timestamp":1777370901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":29,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-200108","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}